List of works - Ana Isabel Tomaz

A novel V(IV)O-pyrimidinone complex: synthesis, solution speciation and human serum protein binding

scientific article published in September 2013

A novel vanadyl complex with a polypyridyl DNA intercalator as ligand: a potential anti-protozoa and anti-tumor agent

scientific article

Anticancer activity of structurally related ruthenium(II) cyclopentadienyl complexes

scientific article published on 23 February 2014

Antitumour and Toxicity Evaluation of a Ru(II)-Cyclopentadienyl Complex in a Prostate Cancer Model by Imaging Tools

scientific article published on 01 January 2019

Biospeciation of various antidiabetic V(IV)O compounds in serum

scientific article published on 12 February 2009

Cellular uptake mechanisms of an antitumor ruthenium compound: the endosomal/lysosomal system as a target for anticancer metal-based drugs

scientific article published on 24 June 2013

DNA cleavage activity of V IV O(acac)2 and derivatives

scientific article published on 18 January 2009

Design of vanadium mixed-ligand complexes as potential anti-protozoa agents

scientific article published on 7 November 2008

Effect of the Metal Ion on the antiT. cruziActivity and Mechanism of Action of 5-Nitrofuryl-Containing Thiosemicarbazone Metal Complexes

Electronic properties of a cytosine decavanadate: toward a better understanding of chemical and biological properties of decavanadates

scientific article

Evaluation of the binding of oxovanadium(IV) to human serum albumin

scientific article published on 5 April 2012

Experimental data on novel Fe(III)-complexes containing phenanthroline derivatives for their anticancer properties

scientific article published on 27 September 2019

Important cytotoxicity of novel iron(II) cyclopentadienyl complexes with imidazole based ligands.

scientific article published on 31 July 2013

In vivo Performance of a Ruthenium-cyclopentadienyl Compound in an Orthotopic 1 Triple Negative Breast Cancer Model

Insights into the mechanisms underlying the antiproliferative potential of a Co(II) coordination compound bearing 1,10-phenanthroline-5,6-dione: DNA and protein interaction studies

scientific article published on 31 January 2014

Interaction and lipid-induced conformation of two cecropin-melittin hybrid peptides depend on peptide and membrane composition.

scientific article published in September 2005

Interaction of vanadium(IV) with human serum apo-transferrin.

scientific article

Interaction with Blood Proteins of a Ruthenium(II) Nitrofuryl Semicarbazone Complex: Effect on the Antitumoral Activity

scientific article published on 07 August 2019

May iron(III) complexes containing phenanthroline derivatives as ligands be prospective anticancer agents?

scientific article published on 13 May 2019

Molecular modelling studies of N-salicylideneamino acidato complexes of oxovanadium(iv). Molecular and crystal structure of a new dinuclear LOVIV–O–VVOL mixed valence complex

New polydentate Ru(III)-Salan complexes: Synthesis, characterization, anti-tumour activity and interaction with human serum proteins

New ternary iron(iii) aminobisphenolate hydroxyquinoline complexes as potential therapeutic agents

scientific article published on 24 May 2019

Novel ruthenium(II) cyclopentadienyl thiosemicarbazone compounds with antiproliferative activity on pathogenic trypanosomatid parasites.

scientific article published on 30 June 2015

Oxovanadium(IV) complexes with aromatic aldehydes

scientific article published on 01 May 2000

Preparation and characterisation of vanadium complexes derived from salicylaldehyde or pyridoxal and sugar derivatives

article by João Costa Pessoa et al published December 2003 in Inorganica Chimica Acta

Ru( p-cymene) Compounds as Effective and Selective Anticancer Candidates with No Toxicity in Vivo

article

Screening organometallic binuclear thiosemicarbazone ruthenium complexes as potential anti-tumour agents: cytotoxic activity and human serum albumin binding mechanism

scientific article published on May 2013

Searching for gallium bioactive compounds: Gallium(III) complexes of tridentate salicylaldehyde semicarbazone derivatives

scholarly article by Dinorah Gambino et al published April 2011 in Polyhedron

Studies on the mechanism of action of antitumor bis(aminophenolate) ruthenium(III) complexes

scientific article published on 14 December 2016

The effect of phosphate on the nuclease activity of vanadium compounds

scientific article

The key role of coligands in novel ruthenium(II)-cyclopentadienyl bipyridine derivatives: Ranging from non-cytotoxic to highly cytotoxic compounds.

scientific article

The systems V(IV)O(2+)-glutathione and related ligands: a potentiometric and spectroscopic study

scientific article

Thiolate-S as anchoring donor in the binary and ternary VO(IV) complexes of mercaptopropionylglycine

Tracking antitumor metallodrugs: promising agents with the Ru(II)- and Fe(II)-cyclopentadienyl scaffolds

scientific article published on 20 April 2016

Transport of Therapeutic Vanadium and Ruthenium Complexes by Blood Plasma Components

scientific article published on 01 January 2010

Uptake and metabolic effects of insulin mimetic oxovanadium compounds in human erythrocytes

scientific article published on 14 October 2005

VIVO and CuII complexation by ligands based on pyridine nitrogen donors

scientific article published on 14 September 2012

Vanadium (IV and V) Complexes of Reduced Schiff Bases Derived from the Reaction of Aromatico-Hydroxyaldehydes and Diamines Containing Carboxyl Groups

Vanadium compounds as therapeutic agents: some chemical and biochemical studies.

scientific article published on 20 November 2008

Vanadium(IV) and -(V) Complexes of Reduced Schiff Bases Derived from Aromatic o-Hydroxyaldehydes and Tyrosine Derivatives

[RuII(η⁵-C₅H₅)(bipy)(PPh₃)]⁺, a promising large spectrum antitumor agent: cytotoxic activity and interaction with human serum albumin.

scientific article

List of works by Ana Isabel Tomaz

A novel V(IV)O-pyrimidinone complex: synthesis, solution speciation and human serum protein binding

A novel vanadyl complex with a polypyridyl DNA intercalator as ligand: a potential anti-protozoa and anti-tumor agent

Anticancer activity of structurally related ruthenium(II) cyclopentadienyl complexes

Antitumour and Toxicity Evaluation of a Ru(II)-Cyclopentadienyl Complex in a Prostate Cancer Model by Imaging Tools

Biospeciation of various antidiabetic V(IV)O compounds in serum

Cellular uptake mechanisms of an antitumor ruthenium compound: the endosomal/lysosomal system as a target for anticancer metal-based drugs

DNA cleavage activity of V IV O(acac)2 and derivatives

Design of vanadium mixed-ligand complexes as potential anti-protozoa agents

Effect of the Metal Ion on the antiT. cruziActivity and Mechanism of Action of 5-Nitrofuryl-Containing Thiosemicarbazone Metal Complexes

Electronic properties of a cytosine decavanadate: toward a better understanding of chemical and biological properties of decavanadates

Evaluation of the binding of oxovanadium(IV) to human serum albumin

Experimental data on novel Fe(III)-complexes containing phenanthroline derivatives for their anticancer properties

Important cytotoxicity of novel iron(II) cyclopentadienyl complexes with imidazole based ligands.

In vivo Performance of a Ruthenium-cyclopentadienyl Compound in an Orthotopic 1 Triple Negative Breast Cancer Model

Insights into the mechanisms underlying the antiproliferative potential of a Co(II) coordination compound bearing 1,10-phenanthroline-5,6-dione: DNA and protein interaction studies

Interaction and lipid-induced conformation of two cecropin-melittin hybrid peptides depend on peptide and membrane composition.

Interaction of vanadium(IV) with human serum apo-transferrin.

Interaction with Blood Proteins of a Ruthenium(II) Nitrofuryl Semicarbazone Complex: Effect on the Antitumoral Activity

May iron(III) complexes containing phenanthroline derivatives as ligands be prospective anticancer agents?

Molecular modelling studies of N-salicylideneamino acidato complexes of oxovanadium(iv). Molecular and crystal structure of a new dinuclear LOVIV–O–VVOL mixed valence complex

New polydentate Ru(III)-Salan complexes: Synthesis, characterization, anti-tumour activity and interaction with human serum proteins

New ternary iron(iii) aminobisphenolate hydroxyquinoline complexes as potential therapeutic agents

Novel ruthenium(II) cyclopentadienyl thiosemicarbazone compounds with antiproliferative activity on pathogenic trypanosomatid parasites.

Oxovanadium(IV) complexes with aromatic aldehydes

Preparation and characterisation of vanadium complexes derived from salicylaldehyde or pyridoxal and sugar derivatives

Ru( p-cymene) Compounds as Effective and Selective Anticancer Candidates with No Toxicity in Vivo

Screening organometallic binuclear thiosemicarbazone ruthenium complexes as potential anti-tumour agents: cytotoxic activity and human serum albumin binding mechanism

Searching for gallium bioactive compounds: Gallium(III) complexes of tridentate salicylaldehyde semicarbazone derivatives

Studies on the mechanism of action of antitumor bis(aminophenolate) ruthenium(III) complexes

The effect of phosphate on the nuclease activity of vanadium compounds

The key role of coligands in novel ruthenium(II)-cyclopentadienyl bipyridine derivatives: Ranging from non-cytotoxic to highly cytotoxic compounds.

The systems V(IV)O(2+)-glutathione and related ligands: a potentiometric and spectroscopic study

Thiolate-S as anchoring donor in the binary and ternary VO(IV) complexes of mercaptopropionylglycine

Tracking antitumor metallodrugs: promising agents with the Ru(II)- and Fe(II)-cyclopentadienyl scaffolds

Transport of Therapeutic Vanadium and Ruthenium Complexes by Blood Plasma Components

Uptake and metabolic effects of insulin mimetic oxovanadium compounds in human erythrocytes

VIVO and CuII complexation by ligands based on pyridine nitrogen donors

Vanadium (IV and V) Complexes of Reduced Schiff Bases Derived from the Reaction of Aromatico-Hydroxyaldehydes and Diamines Containing Carboxyl Groups

Vanadium compounds as therapeutic agents: some chemical and biochemical studies.

Vanadium(IV) and -(V) Complexes of Reduced Schiff Bases Derived from Aromatic o-Hydroxyaldehydes and Tyrosine Derivatives

[RuII(η⁵-C₅H₅)(bipy)(PPh₃)]⁺, a promising large spectrum antitumor agent: cytotoxic activity and interaction with human serum albumin.